BING, vps13d (3178-3190)

General Information


DRACP ID  DRACP04185

Peptide Name   BING, vps13d (3178-3190)

Sequence  IRIILRAQGALKI

Sequence Length  13

UniProt ID  A0A3B3H3X8 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C67H125N21O15

Absent amino acids  CDEFHMNPSTVWY

Common amino acids  I

Mass  167911

Pl  12.52

Basic residues  3

Acidic residues  0

Hydrophobic residues  8

Net charge  3

Boman Index  -685

Hydrophobicity  95.38

Aliphatic Index  195.38

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34108601

Title  BING, a novel antimicrobial peptide isolated from Japanese medaka plasma, targets bacterial envelope stress response by suppressing cpxR expression

Doi Not available

Year  2021

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  18236

DRACP is developed by Dr.Zheng's team.